从 levetiracetam 转换到 brivaracetam 之前和之后的精神病学评估
Ammar Kassoum1, Tassanai Intravooth2, Anne-Sophie Wendling2
1Department of Adult Epilepsy, Kork Epilepsy Center, Landstr. 1, Kehl-Kork, Germany; Department of Neurology and Clinical Neuroscience, Medical Faculty, University of Freiburg, Breisacher Str. 64, Freiburg, Germany.
Seizure
|March 9, 2024
概括
在患者中从 levetiracetam 转换为 brivaracetam 并没有增加精神病风险. 布里瓦拉塞坦组的心理评分有所改善,这表明在管理方面存在潜在的益处.
科学领域:
- 神经学 神经学
- 精神病学是一个精神病学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 列维是一种常见的抗药物.
- 一些患者经历了 levetiracetam 的精神疾病不良事件或疗效问题.
- 布里瓦拉是一种替代性抗药物.
研究的目的:
- 评估因精神问题而从 levetiracetam 转换为布里瓦拉塞坦的患者的心理状况.
- 为了比较切换到布里瓦拉塞坦的患者和继续服用 levetiracetam的患者之间的心理结果.
主要方法:
- 使用的症状检查清单SCL-90-R和贝克抑郁症清单II用于心理评估.
- 在基线和转换/延续8天后收集的数据.
- 采用统计方法来比较切换组和继续组之间的心理变化.
主要成果:
- 转换为布里瓦拉塞坦的患者在基线焦虑和精神病症得分较高.
- 在切换后,所有心理分数在不同组之间得到改善和正常化.
- 最初的单疗法和男性性别预测了心理改善.
结论:
- 从 levetiracetam 切换到 brivaracetam 并没有增加精神病风险.
- 在布里瓦拉塞坦组中,改善精神病学结果的趋势需要进一步调查.
- 布里瓦拉对于患有精神病耐受性问题的患者来说可能是一个可行的选择.
相关概念视频
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
296
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
296
Electroconvulsive Therapy
39
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
39
Seizures: Classification
347
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
347
Antiepileptic Drugs: Potassium Channel Activators
183
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
183
Antiepileptic Drugs: GABAergic Pathway Potentiators
399
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
399
Mania and Antimanic Drugs: Overview
179
Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as...
179


